EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gasdermin C sensitizes tumor cells to PARP inhibitor therapy in cancer models

Shuanglian Wang, Chiung-Wen Chang, Juan Huang, Shan Zeng, Xin Zhang, Mien-Chie Hung, Junwei Hou

Journal of Clinical Investigation · 02.01.2024 · 134 (1)

DOI: 10.1172/jci166841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.01.2024. Verfasst von Shuanglian Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Council Taiwan, Ministry of Health and Welfare Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) Polymerase InhibitorsNeoplasmsHumansAnimalsMiceGasderminsApoptosisPyroptosisTumor MicroenvironmentBiomarkers, Tumor

Stichwörter der Autor:innen

CancerDrug therapyOncologyT cellsTherapeutics

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsGasderminsGSDMC protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery.
  • Xiangya Cancer Center, and.
  • Center for Molecular Oncology and Immunology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha, Hunan, China.
  • Clinical Research Center for Pharyngolaryngeal Diseases and Voice Disorders in Hunan Province, Changsha, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Council Taiwan
  • Ministry of Health and Welfare Taiwan
  • National Key R&D Program of China

Zitieren

APA

Wang, S., Chang, C. W., Huang, J., Zeng, S., Zhang, X., Hung, M. C., & Hou, J. (2024). Gasdermin C sensitizes tumor cells to PARP inhibitor therapy in cancer models. Journal of Clinical Investigation, 134(1). https://doi.org/10.1172/jci166841

Vancouver

Wang S, Chang CW, Huang J, Zeng S, Zhang X, Hung MC, et al. Gasdermin C sensitizes tumor cells to PARP inhibitor therapy in cancer models. Journal of Clinical Investigation. 2024;134(1). doi:10.1172/jci166841

BibTeX
@article{Wang2024,
  author = {Wang, Shuanglian and Chang, Chiung-Wen and Huang, Juan and Zeng, Shan and Zhang, Xin and Hung, Mien-Chie and Hou, Junwei},
  title = {Gasdermin C sensitizes tumor cells to PARP inhibitor therapy in cancer models},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {1},
  doi = {10.1172/jci166841}
}
Kostenlos starten →